Yongping CrawfordAssociate Director at NGM Biopharmaceuticals
Yongping Crawford heads the Cell Line Development and Engineering (CLDE) group at NGM Biopharmaceuticals. Her group supports all pipeline projects at NGM and manages outsourcing activities at CMOs. Under her leadership, the CLDE team at NGM has improved the performance for a commonly used commercially available expression platform by four fold. Previously, Yongping was a group leader in Early Stage Cell Culture department at Genentech, where she led the effort in developing and implementing a Targeted Integration host for CLD. Yongping received her PhD from University of California, San Francisco, and completed her postdoctoral training at Genentech.